Molecular approaches to the Rett syndrome gene

Journal of Child Neurology

Volumn 14, Issue 12, 1999, Pages 806-814

  Schanen, N Carolyn ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 O METHYLDOPAMINE; 5 HYDROXYINDOLEACETIC ACID; AMPA RECEPTOR; DOPAMINE; DOPAMINE RECEPTOR; HOMOVANILLIC ACID; NORADRENALIN; SEROTONIN; TYROSINE 3 MONOOXYGENASE;

CELL MATURATION; CHROMOSOME XQ; DEVELOPMENTAL DISORDER; FAMILIAL DISEASE; GENE MAPPING; HUMAN; NERVOUS SYSTEM DEVELOPMENT; PHENOTYPE; PRIORITY JOURNAL; RETT SYNDROME; REVIEW; X CHROMOSOME DOMINANT DISORDER;

EID: 0033398783     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307389901401207     Document Type: Review

References (142)

1. Rett A: Uber ein eigenartiges hirnatrophisches syndrom bei Hyperammonamie im. Kinsesalter Wein Med Wochenschr 1966;116: 723-738.
2. Hagberg B, Aicardi J, Dias K, et al: A progressive syndrome of autism, dementia, ataxia and loss of purposeful hand use in girls: Rett's syndrome: Report of 35 cases. Ann Neurol 1983;14:471-479.
3. Rett Syndrome Diagnostic Criteria Work Group: Diagnostic criteria for Rett syndrome. Ann Neurol 1988;23:425-428.
4. Olsson B, Rett A: Autism and Rett syndrome: Behavioural investigations and differential diagnosis. Dev Med Child Neurol 1987;29: 429-441.
5. Hagberg B: Rett's syndrome: Prevalence and impact on progressive severe mental retardation in girls. Acta Paediatr Scand 1985; 74:405-408.
6. Kozinetz CA, Skender ML, MacNaughton N, et al: Epidemiology of Reft syndrome: A population-based registry. Pediatrics 1993;91: 445-450.
7. Skjeldal OH, von Tetzchner S, Aspelund F, et al: Rett syndrome: Geographic variation in prevalence in Norway. Brain Dev 1997;19: 258-261.
8. Hagberg B, Witt Engerstrom I: Rett syndrome: A suggested staging system for describing impairment profile with increasing age towards adolescence. Am J Med Genet 1986;1(Suppl):47-59.
9. Kerr AM: A review of the respiratory disorder in the Rett syndrome. Brain Dev 1992;14(Suppl):S43-S45.
10. Hennessy MJ, Haas RH: The orthopedic management of Rett syndrome. J Child Neurol 1988;3:S43-S47.
11. Bassett GS, Tolo VT; The incidence and natural history of scoliosis in Rett syndrome. Dev Med Child Neurol 1990;32:963-966.
12. Haas RH, Dixon SD, Sartoris DJ, et al: Osteopenia in Rett syndrome. J Pediatr 1997;131:771-774.
13. Naidu S, Chatterjee S, Murphy M, et al: Rett syndrome: New observations. Brain Dev 1987;9:525-528.
14. Holm VA: Physical growth and development in patients with Rett syndrome. Am JMed Genet 1986;1(Suppl):119-126.
15. Schultz RJ, Glaze DG, Motil KJ, et al: The pattern of growth failure in Rett syndrome. Am J Dis Child 1993;147:633-637.
16. Motil KJ, Schultz R, Brown B, et al: Altered energy balance may account for growth failure in Rett syndrome. J Child Neurol 1994;9:315-319.
17. Sekul EA, Moak JP, Schultz RJ, et al: Electrocardiographic findings in Rett syndrome: An explanation for sudden death? J Pediatr 1994;125:80-82.
18. Julu PO, Kerr AM, Hansen S, et al: Immaturity of medullary cardiorespiratory neurones leading to inappropriate autonomic reactions as a likely cause of sudden death in Rett's syndrome. Arch Dis Child 1997;77:464-465.
19. Burd L, Martsolf JT, Randall T: A prevalence study of Rett syndrome in an institutionalized population. Am J Med Genet 1990;36:33-36.
20. Goutieres F, Aicardi J: Rett syndrome: Clinical presentation and laboratory investigations in 12 further French patients. Brain Dev 1985;7:305-306.
21. Cameron D, Losty H, Wallace S: The Rett syndrome and ornithylcarbamoyl transferase deficiency, letter. Brain Dev 1991;13:138.
22. Carpenter KH, Bonham JR, Clarke A: Rett's syndrome and ornithine carbamoyltransferase deficiency. J Inherit Metab Dis 1990;13: 308-310.
23. Clarke A, Gardner MD, Richardson J, et al: Abnormalities of carbohydrate metabolism and of OCT gene function in the Rett syndrome. Brain Dev 1990;12:119-124.
24. Haas RH, Rice MA, Trauner DA, et al: Therapeutic effects of a ketogenic diet in Rett syndrome. Am J Med Genet 1986;1(Suppl): 225-246.
25. Lappalainen R, Riikonen RS: Elevated CSF lactate in the Rett syndrome: Cause or consequence? Brain Dev 1994;16:399-401.
26. Suzuki H, Matsuzaka T, Hirayama Y, et al: Rett's syndrome: Progression of symptoms from infancy to childhood. J Child Neurol 1986;1:137-141.
27. Riederer P, Brucke T, Sofic E, et al: Neurochemical aspects of the Rett syndrome. Brain Dev 1985;7:351-360.
28. Zoghbi HY, Milstien S, Butler LJ, et al: Cerebrospinal fluid biogenic amines and biopterin in Rett syndrome. Ann Neurol 1989;25:56-60.
29. Lekman A, Witt Engerstrom I, Holmberg B, et al: CSF and urine biogenic amine metabolites in Rett syndrome. Clin Genet 1990;37: 173-178.
30. Percy AK: Neurochemistry of the Rett syndrome. Brain Dev 1992; 14:S57-S62.
31. Lekman A, Witt Engerstrom I, Gottfries J, et al: Rett syndrome: Biogenic amines and metabolites in postmortem brain. Pediatr Neurol 1989;5:357-362.
32. Armstrong DD: The neuropathology of Rett syndrome - overview 1994. Neuropediatrics 1995;26:100-104.
33. Jellinger K, Seitelberger F: Neuropathology of Rett syndrome. Am. J Med Genet 1986;1(Suppl):259-288.
34. Jellinger K, Armstrong D, Zoghbi HY, et al: Neuropathology of Rett syndrome. Acta Neuropathol (Berl) 1988;76:142-158.
35. Kitt CA, BJ Wilcox: Preliminary evidence for neurodegenerative changes in the substantia nigra of Rett syndrome. Neuropediatrics 1995;26:114-118.
36. Subramaniam B, Naidu S, Reiss AL: Neuroanatomy in Rett syndrome: Cerebral cortex and posterior fossa. Neurology 1997;48: 399-407.
37. Naidu S: Rett syndrome: A disorder affecting early brain growth. Ann Neurol 1997:42:3-10.
38. Chiron C, Bulteau C, Loc'h C, et al: Dopaminergic D2 receptor SPECT imaging in Rett syndrome: Increase of specific binding in striatum. J Nucl Med 1993;34:1717-1721.
39. Wenk G: Selective changes in Rett syndrome neurochemistry: Findings of normal dopaminergic and decreased cholinergic function. World Congress on Rett Syndrome, Gothenburg, Sweden, 1996, p 80.
40. Wenk G: Alterations in dopaminergic function in Rett syndrome. Neuropediatrics 1995;26:123-125.
41. Perry BD, Vigilante D, Armstrong D: Altered dopaminergic receptor binding sites in the caudate nucleus of subjects with Rett syndrome. World Congress on Rett Syndrome, Gothenburg, Sweden, 1996, p 104.
42. Sahota A, Leeming R, Blair J, et al: Tetrahydrobiopterin metabolism in the Rett disease. Brain Dev 1985;7:249-250.
43. Blue ME, Naidu S, Moser H, et al: Glutamate receptor density is decreased in basal ganglia of patients with Rett syndrome. Soc Neurosci Abstr 1995;21:735.
44. Blue ME, Hohmann CF, Wallace SA, et al: Changes in excitatory and inhibitory neurotransmitter receptors in Rett syndrome and in a mouse model for Rett syndrome. World Congress on Rett Syndrome, Gothenburg, Sweden, 1996, p 89.
45. Lappalainen R, Riikonen RS: High levels of cerebrospinal fluid glutamate in Rett syndrome. Pediatr Neurol 1996;15:213-216.
46. Yamashita Y, Matsuishi T, Ishibashi M, et al: Decrease in benzodiazepine receptor binding in the brains of adult patients with Rett syndrome. J Neurol Sci 1998;154:146-150.
47. Budden SS, Myer EC, Butler IJ: Cerebrospinal fluid studies in the Rett syndrome: Biogenic amines and beta-endorphins. Brain Dev 1990;12:81-84.
48. Myer EC, Tripathi HL, Brase DA, et al: Elevated CSF beta-endorphin immunoreactivity in Rett's syndrome: Report of 158 cases and comparison with leukemic children. Neurology 1992;42:357-360.
49. Wenk GL, O'Leary M, Nemeroff CB, et al: Neurochemical alterations in Rett syndrome. Bra in Res Dev Brain Res 1993;74:67-72.
50. Lappalainen R, Lindholm D, Riikonen R: Low levels of nerve growth factor in cerebrospinal fluid of children with Rett syndrome. J Child Neurol 1996;11:296-300.
51. Burroni L, Aucone AM, Volterrani D, et al: Brain perfusion abnormalities in Rett syndrome: A qualitative and quantitative SPET study with 99Tc(m)-ECD. Nucl Med Comm 1997;18:527-534.
52. Lappalainen R, Liewendahl K, Sainio K, et al: Brain perfusion SPECT and EEG findings in Rett syndrome. Acta Neurol Scand 1997;95:44-50.
53. Armstrong D, Dunn JK, Antalffy B, et al: Selective dendritic alterations in the cortex of Rett syndrome. J Neuropath Exp Neurol 1995;54:195-201.
54. Belichenko PV, Dahlström A: Studies on the 3-dimensional architecture of dendritic spines and varicosities in human cortex by confocal laser scanning microscopy and Lucifer yellow microinjections. J Neurosci Methods 1995;57:55-61.
55. Armstrong DD: Review of Rett syndrome. J Neuropath Exp Neurol 1997;56:843-849.
56. Armstrong DD: The neuropathology of the Rett syndrome. Brain Dev 1992;14:S89-S98.
57. Kaufmann WE, Worley PF, Taylor CV, et al: Cyclooxygenase-2 expression during rat neocortical development and in Rett syndrome. Brain Dev 1997;19:25-34.
58. Kaufmann WE, Naidu S, Budden S: Abnormal expression of microtubule-associated protein 2 (MAP-2) in neocortex in Rett syndrome. Neuropediatrics 1995;26:109-113.
59. Bauman ML, Kemper TL, Arin DM: Pervasive neuroanatomic abnormalities of the brain in three cases of Rett's syndrome. Neurology 1995;45:1581-1586.
60. Armstrong D: Morphological studies of selective developmental arrest in Rett syndrome. World Congress on Rett Syndrome, Gothenburg, Sweden, 1996, p 16.
61. Belichenko PV, Oldfors A, Hagberg B, et al: Rett syndrome: 3-D confocal microscopy of cortical pyramidal dendrites and afferents. Neuroreport 1994;5:1509-1513.
62. Belichenko PV, Fedorov AA, Dahlström AB: Quantitative analysis of immunofluorescence and lipofuscin distribution in human cortical areas by dual-channel confocal laser scanning microscopy. J Neurosci Methods 1996;69:155-161.
63. Belichenko PV, Hagberg B, Dahlström A: Morphological study of neocortical areas in Rett syndrome. Acta Neuropathol 1997;93: 50-61.
64. Oldfors A, Sourander P, Armstrong DL, et al: Rett syndrome: Cerebellar pathology. Pediatr Neural 1990;6:310-314.
65. Oldfors A, Hagberg B, Nordgren H, et al: Rett syndrome: Spinal cord neuropathology. Pediatr Neurol 1988;4:172-174.
66. Jellinger K, Grisold W, Armstrong D, et al: Peripheral nerve involvement: in the Rett syndrome. Brain Dev 1990;12:109-114.
67. Ruch A, Kurczynski TW, Velasco ME: Mitochondrial alterations in Rett syndrome. Pediatr Neurol 1989;5:320-323.
68. Mak SC, Chi CS, Chen CH, et al: Abnormal mitochondria in Rett syndrome: One case report. Chung Hua I Hsueh Tsa Chih (Taipei) 1993;52:116-119.
69. Dotti MT, Manneschi L, Malandrini A, et al: Mitochondrial dysfunction in Rett syndrome. An ultrastructural and biochemical study. Brain Dev 1993;15:103-106.
70. Zoghbi H: Genetic aspects of Rett syndrome. J Child Neurol 1988;3:S76-S78.
71. Witt Engerstrom I, Forslund M: Mother and daughter with Rett syndrome. Dev Med Child Neurol 1992;34:1022-1023.
72. Comings DE: The genetics of Rett syndrome: The consequences of a disorder where every case is a new mutation. Am J Med Genet 1986;1(Suppl):383-388.
73. Murphy M, Naidu S, Moser H: Rett syndrome - observational study in 33 families. Am J Med Genet 1986;24:73-76.
74. Buhler EM, Malik NJ, Alkan M: Another model for the inheritance of Rett syndrome. Am J Med Genet 1990;36:126-131.
75. Migeon BR, Dunn MA, Thomas G, et al: Studies of X inactivation and isodisomy in twins provide further evidence that the X chromosome is not involved in Rett syndrome. Am J Hum Genet 1995;56:647-653.
76. Hofferbert S, Schanen NC, Budden SS, et al: Is Rett syndrome caused by a triplet repeat expansion? Neuropediatrics 1997;28: 179-183.
77. Haas RH, Light M, Rice M, et al: Oxidative metabolism in Rett syndrome: 1. Clinical studies. Neuropediatrics 1995;26:90-94.
78. Haas RH, Nasirian F, Hua X, et al: Oxidative metabolism in Rett syndrome: 2. Biochemical and molecular studies. Neuropediatrics 1995;26:95-99.
79. Tang J, Qi Y, Bao XH, et al: Mutational analysis of mitochondrial DNA of children with Rett syndrome. Pediatr Neurol 1997;17: 327-330.
80. Killian W: On the genetics of Rett syndrome: Analysis of family and pedigree data. Am J Med Genet 1986;1(Suppl):369-376.
81. Willard HF: X chromosome inactivation and X-linked mental retardation. Am J Med Genet 1996;64:21-2G.
82. Puck J, Willard HF: X inactivation in females with X-linked disease. N Engl J Med 1998;338:325-328.
83. Vorsanova SG, Demidova IA, Ulas V, et al: Cytogenetic and molecular-cytogenetic investigation of Rett syndrome: Analysis of 31 cases. Neuroreport 1996;8:187-189.
84. Schanen NC, Dahle EJ, Capozzoli F, et al: A new Rett syndrome family consistent with X-linked inheritance expands the X chromosome exclusion map. Am J Hum Genet 1997;61:634-641.
85. Schanen NC, Kurczynski TW, Brunelle D, et al: Neonatal encephalopathy in two boys in families with recurrent Rett syndrome. J Child Neurol 1998;13:229-231.
86. Thomas GH: High male:female ratio of germ-line mutations: An alternative explanation for postulated gestational lethality in males in X-linked dominant disorders. Am J Hum Genet 1996;58: 1364-1368.
87. Bonaiti-Pellie C, Pelet A, Ogier H, et al: A probable difference in mutation rate in ornithine transcarbamylase deficiency. Hum Genet 1990;84:163-166.
88. Wirth B, Schmidt T, Hahnen E, et al: De novo rearrangements found in 2% of index patients with spinal muscular atrophy: Mutational mechanisms, parental origin, mutation rate, and implications for genetic counseling. Am J Hum Genet 1997;61:1102-1111.
89. Wilkin DJ, Szabo JK, Cameron R, et al: Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome. Am J Hum Genet 1998;63:711-716.
90. Robinson WP, Dutly F, Nicholls RD, et al: The mechanisms involved in formation of deletions and duplications of 15q11-q13. J Med Genet 1998;35:130-136.
91. Becker J, Schwaab R, Moller-Taube A, et al: Characterization of the factor VIII defect in 147 patients with sporadic hemophilia A: Family studies indicate a mutation type-dependent sex ratio of mutation frequencies. Am J Hum Genet 1996;58:657-670.
92. Lopes J, Ravise N, Vandenberghe A, et al: Fine mapping of de novo CMT1A and HNPP rearrangements within CMT1A-REPs evidences two distinct sex-dependent mechanisms and candidate sequences involved in recombination. Hum Mol Genet 1998;7: 141-148.
93. Blair IP, Nash J, Gordon MJ, et al: Prevalence and origin of de novo duplications in Charcot-Marie-Tooth disease type 1A: First report of a de novo duplication with a maternal origin. Am J Hum Genet 1996;58:472-476.
94. Rousseau F, Bonaventure J, Legeai-Mallet L, et al: Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 1994;371:252-254.
95. Moloney DM, Slaney SF, Oldridge M, et al: Exclusive paternal origin of new mutations in Apert syndrome. Nat Genet 1996;13:48-53.
96. Lyon MF: Gene action in the X-chromosome of the mouse. Nature 1961;190:372-373.
97. Goodfellow PN, Pym B, Mohandas T, et al: The cell surface antigen locus, MIC2X, escapes X inactivation. Am J Hum Genet 1984; 36:777-782.
98. Fisher EMC, Beer-Romero P, Brown LG, et al: Homologous ribosomal protein genes on the human X and Y chromosomes: Escape from X inactivation and possible implications for Turner syndrome. Cell 1990;63:1205-1218.
99. Schneider-Gadicke A, Beer-Romero P, Brown LG, et al: ZFX has a gene structure similar to ZFY, the putative sex determinant, and escapes X inactivation. Cell 1989;57:1247-1258.
100. Riccardi VM: The Rett syndrome: Genetics and future. Am J Med Genet 1986;24:389-402.
101. Webb T, Watkiss E, Woods CG: Neither uniparental disomy nor skewed X-inactivation explains Rett syndrome. Clin Genet 1993;44: 236-240.
102. Camus P, Abbadi N, Ferner MC, et al: X chromosome inactivation in 30 girls with Rett syndrome: Analysis using the probe M27beta. Hum Genet 1996;97:247-250.
103. Zoghbi HY, Percy AK, Schultz RJ, et al: Patterns of X chromosome inactivation in the Rett syndrome. Brain Dev 1990;12:131-135.
104. Webb T, Watkiss E: A comparative study of X-inactivation in Rett syndrome probands and control subjects. Clin Genet 1996;49: 189-195.
105. Krepischi AC, Kok F, Otto PG: X chromosome-inactivation patterns in patients with Rett syndrome. Hum Genet 1998;102:319-321.
106. Panasiuk B, Midro AT, Zadrozna-Towinska B: Earlier finishing of Xp21.2 subband replication of the inactive X chromosome in Rett syndrome girl but not in her 47,XXX mother. Clin Genet 1997;52: 120-125.
107. Jorgensen AL, Philip J, Raskind WH, et al: Different patterns of X inactivation in MZ twins discordant for red-green color-vision deficiency. Am J Hum Genet 1992;51:291-298.
108. Sirianni N, Naidu S, Pereira J, et al: Rett syndrome: Confirmation of X-linked dominant inheritance, and localization of the gene to Xq28. Am J Hum Genet 1998;63:1552-1558.
109. Archidiacono N, Lerone M, Rocchi M, et al: Rett syndrome: Exclusion mapping following the hypothesis of germinal mosaicism for new X-linked mutations. Hum Genet 1991;86:604-606.
110. Ellison KA, Fill CP, Terwilliger J, et al: Examination of X chromosome markers in Rett syndrome: Exclusion mapping with a novel variation on multilocus linkage analysis. Am J Hum Genet 1992;50:278-287.
111. Curtis AR, Headland S, Lindsay S, et al: X chromosome linkage studies in familial Rett syndrome. Hum Genet 1993;90:551-555.
112. Schanen C, Francke U: A severely affected male born into a Rett syndrome kindred supports X-linked inheritance and allows extension of the exclusion map. Am J Hum Genet 1998;63:267-269.
113. Xiang FQ, Zhang ZP, Clarke A, et al: Chromosome mapping of Rett syndrome: A likely candidate region on the telomere of Xq. J Med Genet 1998;35:297-300.
114. Bienvenu T, des Portes V, Saint Martin A, et al: Non-specific X-linked semidominant mental retardation by mutations in a Rab GDP-dissociation inhibitor. Hum Mol Genet 1998 ;7:1311-1315.
115. D'Adamo P, Menegon A, Lo Nigro C, et al: Mutations in GDI1 are responsible for X-linked non-specific mental retardation. Nat Genet 1998;19:134-139.
116. Billuart P, Bienvenu T, Ronce N, et al: Oligophrenin-1 encodes a rhoGAP protein involved in X-linked mental retardation. Nature 1998;392:923-926.
117. Armstrong DD, Dunn K, Antalffy B: Decreased dendritic branching in frontal, motor and limbic cortex in Rett syndrome compared with trisomy 21. J Neuropath Exp Neurol 1998;57:1013-1017.
118. Song H-R, Francke U, Schanen NC: A candidate gene for Rett syndrome: Search for mutations in the UBE2A gene. 5th Joint Clinical Genetics Meeting, Los Angeles, 1998.
119. Heidary G, Hampton LL, Schanen NC, et al: Exclusion of the gastrin-releasing peptide receptor (GRPR) locus as a candidate gene for Rett syndrome - Brief Research Communication. Am J Med Genet 1998;78:173-175.
120. Percy AK, Schanen C, Dure LS: The genetic basis of Rett syndrome: Candidate gene considerations. Mol Genet Metab 1998;64:1-6.
121. Wan MH, Francke U: Evaluation of two X chromosomal candidate genes for Rett syndrome: Glutamate dehydrogenase-2 (GLUD2) and rab GDP-dissociation inhibitor (GDI1) - Brief Research Communication. Am J Med Genet 1998;78:169-172.
122. Cummings CJ, Dahle EJR, Zoghbi HY: Analysis of the genomic structure of the human glycine receptor alpha 2 subunit gene and exclusion of this gene as a candidate for Rett syndrome -Brief Research Communication. Am J Med Genet 1998; 78:176-178.
123. Van den Veyver IB, Subramanian S, Zoghbi HY: Genomic structure of a human holocytochrome c-type synthetase gene in Xp22.3 and mutation analysis in patients with Rett syndrome. Am J Med Genet 1998;78:179-181.
124. Narayanan V, Olinsky S, Dahle E, et al: Mutation analysis of the M6b gene in patients with Rett syndrome. Am J Med Genet 1998; 78:165-168.
125. Motil KJ, Schultz RJ, Wong WW, et al: Increased energy expenditure associated with repetitive involuntary movement does not contribute to growth failure in girls with Rett syndrome. J Pediatr 1998; 132:228-233.
126. Eichler EE, Lu F, Shen Y, et al: Duplication of a gene-rich cluster between 16p11.1 and Xq28: A novel pericentromeric-directed mechanism for paralogous genome evolution. Hum Mol Genet 1996;5:899-912.
127. Eichler EE, Budarf ML, Rocchi M, et al: Interchromosomal duplications of the adrenoleukodystrophy locus: A phenomenon of pericentromeric plasticity. Hum Mol Genet 1997;6:991-1002.
128. Pilia G, Little RD, Aissani A, et al: Isochores and CpG islands in YAC contigs in human Xq26.1-qter. Genomics 1993;17:456-562.
129. Nagaraja R, MacMillan S, Kere J, et al: X chromosome map at 75-kb STS resolution, revealing extremes of recombination and GC content. Genome Res 1997;7:210-222.
130. Nelson DL, Ballabio A, Cremers F, et al: Report of the sixth international workshop on X chromosome mapping 1995. Cytogenet Cell Genet 1995;71:308-336.
131. Amir RE, Van den Veyver IB, Wan M, et al: Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999;23:185-188.
132. D'Esposito M, Quaderi NA, Ciccodicola A, et al: Isolation, physical mapping, and northern analysis of the X-linked human gene encoding methyl CpG-binding protein, MECP2. Mammalian Genome 1996;7:533-535.
133. Adler DA, Quaderi NA, Brown SD, et al: The X-linked methylated DNA binding protein, Mecp2, is subject to X inactivation in the mouse. Mammalian Genome 1995;6:491-492.
134. Chandler SP, Guschin D, Landsberger N, et al: The methyl-CpG binding transcriptional repressor MeCP2 stably associates with nucleosomal DNA. Biochemistry 1999;38:7008-7018.
135. Cross SH, Bird AP: CpG islands and genes. Curr Opin Genet Develop 1995;5:309-314.
136. Nan X, Tate P, Li E, et al: DNA methylation specifies chromosomal localization of MeCP2. Mol Cell Biol 1996;16:414-421.
137. Nan X, Ng HH, Johnson CA, et al: Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 1998;393:386-389.
138. Wade PA, Jones PL, Vermaak D, et al: Histone deacetylase directs the dominant silencing of transcription in chromatin: association with MeCP2 and the Mi-2 chromodomain SWI/SNF ATPase. Cold Spring Harbor Symposia on Quantitative Biology 1998;63:435-445.
139. Bird AP: Gene number, noise reduction and biological complexity. Trends in Genetics 1995;11:94-100.
140. Nan X, Campoy FJ, Bird A: MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 1997;88:471-481.
141. Tate P, Skarnes W, Bird A: The methyl-CpG binding protein MeCP2 is essential for embryonic development in the mouse. Nat Genet 1996;12:205-208.
142. Wan M, Lee S, Zhang X, et al: Rett syndrome and beyond: Recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Manuscript submitted, 1999.